Toronto, ON – Cannabis Growth Opportunity Corporation (“CGOC”, or the “Company”) (CSE: CGOC), a cannabis focused investment corporation with both public and private cannabis holdings, provides an update on Jushi Inc. (“Jushi”), one of its private holdings. Jushi announced the acquisition of Medicinal Excellence in Neurological Disorders, LLC (“MEND“). MEND is a Buffalo, New York-based cannabinoid research company focused…
The emerging global cannabis industry has taken the world by storm, offering investors a potential for growth that hasn’t been seen in decades. However, a lack of education and awareness of the industry’s complexities has left many investors wondering if and how to participate. That’s where a team of dedicated industry experts can help.
At CGOC, we believe the true value of the industry will be seen through a long-term, actively managed strategy. Our team of cannabis industry experts manage a diverse portfolio of private and public investments. Our goal to ensure every investor has access to this opportunity and benefit from the long-term future of this exciting new market.
Click here for more information.
Our Investment Approach
We build and actively manage a diversified portfolio of public and private holdings designed to minimize risk and maximize long-term growth.
Early Mover Advantage
Through the Corporation, you will gain exposure to investment opportunities in the high growth, multifaceted global cannabis industry before many large institutional investors.
Actively Managed Investments
We leverage our combined investment and cannabis experience to actively manage investments in public cannabis companies that have exhibited strong growth and demonstrated great potential for profitability.
We’ve established relationships that allow us to directly source deals with issuers, customize structures and negotiate favorable terms on behalf of the Corporation.
Access to Early and Pre-IPO Deal Flow
Thanks to our network and extensive experience investing in the cannabis sector, our Investment Managers have access to a meaningful deal flow.
Experienced Investment Team
We’ve assembled an experienced and focused group of individuals to oversee due diligence reviews of opportunities and provide ongoing investment monitoring.
Top-down Investment Process
The Corporation’s top-down investment process employs rigorous technical and behavioral analysis to position the portfolio for offence or defense.
Bottom-up Investment Process
The Corporation’s bottom-up investment process will encompass disciplined fundamental, structural and technical analysis.
Aligned Fee Structure
No management salaries or bonuses paid; management and performance fees are based on the Corporation’s share price.
Join Our Mailing List
Be the first to hear CGOC news by signing up for our news alerts.
Mr. Blundell Director, President & COO
25+ years of experience in senior leadership roles and managing teams of over 1,000 employees and extensive experience with mergers and acquisitions, private equity rms and large corporate divestitures.
Mr. Durfy, Director & CIO
Previously Chief Investment Officer at a hedge fund overseeing all portfolio management activities and prior to that, Managing Director of Global Equities for the Ontario Municipal Employees Retirement System (“OMERS”) from 2008-2011.
Mr. Andersen, CPA, CA Director & CFO
Mr. Andersen has over 25 years of experience as a director and senior officer of numerous public and private companies, and has experience working with cannabis companies both domestically and internationally.
Mr. Campbell, Public Markets Portfolio Manager
Mr. Campbell is often quoted in Bloomberg, The Globe and Mail and Small Cap Power and is a regular guest on Business News Network’s Market Call and Market Call Tonight programs.
Mr. Sutton Independent Director
Mr. Sutton co-founded and served as EVP for Supreme Pharmaceuticals from 2013 to 2014 and played an instrumental role in the early days of Invictus MD Strategies Corp., Aurora Cannabis Inc. and CannaRoyalty Corp.
Mr. Richards Independent Director
Mr. Richards is a practicing tax attorney, adjunct professor of law and legal specialist to the United States cannabis industry, advising businesses and owners throughout the U.S.
Mr. Yeoman Independent Director
From 2005 to 2011, Mr. Yeoman served as the CEO of Altus Group, and led the company through a seven-year growth period, increasing revenues from $75MM to $325MM approximately.